Dr. Charles Wilfley Hopley, MD

Dr. Hopley practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Hopley's NPI, 1811251721, was assigned on June 26, 2012. Dr. Hopley holds New Hampshire license 18869.

Dr. Hopley's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Hopley's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Hopley is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Hopley to 3 more hospitals, 1 dialysis center and 1 medical group, each named with a free account. Dr. Hopley's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hopley practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hopley's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Hopley's licenses on file in 3 states: New Hampshire, Colorado and Illinois.

CMS data shows 936 Medicare services from Dr. Hopley across 10 procedure codes in 2024, for 308 Medicare patients. Medicare paid $132,969 for them.

CMS counts 308 Medicare patients who saw Dr. Hopley in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 4.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hopley's median patient age at 69, with 47% women.

In 2024, Dr. Hopley wrote 653 Medicare Part D claims for 129 patients. 95% of them were for generic drugs. CMS names the drug for 509 of them, across 13 drugs with 11 or more claims each, at $17,930 in total drug cost. In 2023, CMS named 462 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hopley for performance year 2024, reported as part of a group. Dr. Hopley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hopley as offering telehealth.

Dmand AI links 7 papers to Dr. Hopley, published from 2011 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Drug Interactions, Peripheral Arterial Disease and Platelet Aggregation Inhibitors. Dr. Hopley's most frequent co-authors are Jeffrey Berger, MBA, MD, Kenneth William Mahaffey, MD and Elizabeth Brett Daily, MD.